Nebulizers Market to Reach US$ 1.7 Bn by 2028, Rise in Prevalence of Asthma, COPD, and Cystic Fibrosis to Drive the Market
Albany NY, United States: According to the report, the global nebulizers market was valued at US$ 1 Bn in 2020 and is projected to expand at a CAGR of 6.6% from 2021 to 2028. A nebulizer is a medical device used for the treatment of respiratory disorders (asthma, COPD, and cystic fibrosis) that converts liquid medication into mist or aerosol. Hence, the medicine can easily reach into the lungs of a patient when inhaled through the mouth or a face mask.
North America was the largest market for nebulizers in 2020. The region dominated the global market due to substantial investments, strong economic growth, and increase in incidence of asthma and COPD. Moreover, technological advancements, surge in access to healthcare services, and entry of new manufacturers are other factors expected to fuel the growth of the market in North America during the forecast period.
Asia Pacific is projected to be a highly lucrative market for nebulizers during the forecast period. The market in the region is anticipated to expand at a high CAGR during the forecast period. Rapid expansion of the market in the region can be attributed to increase in number of asthma and COPD cases, which require rapid treatment.
Request Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1436
Increase in Number of Respiratory Diseases to Drive Market
Respiratory diseases are increasing among individuals due to which they are highly dependent on various inhaling devices such as nebulizers to provide them an ease in breathing. Asthma and COPD become quite crucial and problematic after 65 years of age and hence, requires treatment with the use of nebulizers.
Nebulizers are the preferred choice, as these can convert liquid medication into aerosol or mist. Patients can easily inhale the aerosol through a mouthpiece or facemask (connected to the nebulizer) without feeling uncomfortable.
Pneumatic Nebulizers Segment to Dominate Global Market
In terms of product type, the global nebulizers market has been classified into pneumatic nebulizer, ultrasonic nebulizer, and mesh nebulizer. The pneumatic nebulizers segment accounted for a leading share of the global market in 2020. The demand for pneumatic nebulizer is high due to its cost-effectiveness compared to ultrasonic and mesh nebulizers.
Get COVID-19 Analysis on Nebulizers Market - https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=1436
North America to Dominate Global Market
In terms of region, the global nebulizers market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global nebulizers market in 2020, followed by Europe. The region's dominance can be attributed to highest number of asthma and COPD cases diagnosed in the world.
The market in North America is driven by rise in prevalence of various respiratory disorders such as asthma, cystic fibrosis, and chronic obstructive pulmonary disease (COPD). Other factors such as large geriatric population and rise in demand for personalized medicines are expected to augment the market in the region.
Make an Enquiry Before Buying - https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=1436
Emerging markets in Asia Pacific hold immense growth potential due to rise in prevalence of asthma and bronchitis. Moreover, improving purchasing power, consumer awareness about health issues, and better disease management are likely to fuel the growth of the nebulizers market in Asia Pacific.
The global nebulizers market is fragmented in terms of number of players. Key players in the nebulizers global market include Agilent Technologies, Inc., Allied Healthcare Products, Inc., CareFusion Corporation, Covidien plc, GE Healthcare Ltd., GF Health Products, Inc., Omron Healthcare, Inc., PARI Respiratory Equipment, Inc., and Philips Healthcare.
Browse more Reports by Transparency Market Research:
Breast Cancer Diagnostics Market: Companies in the breast cancer diagnostics market are harnessing the advantages of AI to improve medical outcomes. The AI technology is being increasingly used in additional image modalities with the goal of lowering costs for hospitals as well as payers.
Cellulitis Treatment Market: Proper usage of antibacterial drugs are adequate to treat cellulitis. The global cellulitis treatment market is primarily driven by increase in cases of cellulitis across the world, rise in diagnosis & treatment rate of cellulitis, and improving health care infrastructure.
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through ad hoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.
Transparency Market Research
90 State Street,
Albany NY - 12207
USA - Canada Toll Free: 866-552-3453